Trials
Search / Trial NCT05651009

Comparison of the in Vivo Stability of 2 Cementless TKA Designs

Launched by HELSE MØRE OG ROMSDAL HF · Dec 6, 2022

Trial Information

Current as of January 21, 2025

Active, not recruiting

Keywords

Ct Based Micromotion Analysis Ctma Cementless Tka Uncemented Tka Total Knee Replacement Total Knee Arthroplasty Tkr Gmk Sphere Tritanium

ClinConnect Summary

Total joint replacement is an efficacious treatment for osteoarthritis of hips and knees. Both TKA and Total Hip Artrhoplasties (THA) have excellent implant survivorship. However, patients' satisfaction is lower in TKA than THA. A possible cause of the discrepancy is the unnatural knee kinematics after TKA. Various implants designs have been developed to solve the problem. The most common fixation mode is cemented TKA with good survival up to 15 years. However, newer series in younger patients also have shown lasting survival with cementless implants (Nilsson KG, Prudhon JL). Among various ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Patients referred to Kristiansund Hospital for primary total knee replacement surgery for osteoarthritis with Kellgren \& Lawrence grade 3 or 4
  • Exclusion Criteria:
  • Preoperative severe deformity (Hip-Knee-Ankle angle of \>5 (valgus) or \<-15 degrees (varus) on a full-length leg image at weight bearing
  • Preoperative flexion contracture more than 15°
  • Less than 50 and more than 75 years of age at the time of surgery
  • Use of walking aids because of other musculoskeletal and neuromuscular problems
  • Preoperative diagnosis other than osteoarthritis or avascular necrosis (e.g. rheumatoid arthritis, tumours)
  • Revision arthroplasty
  • Obesity with BMI\>35 g/m2
  • Lateral collateral ligament deficient knee
  • Previous knee joint infection
  • Cognitive dysfunction or severe psychiatric disorders.

Trial Officials

Frank-David Øhrn, MD, PhD

Study Director

Møre og Romsdal Hospital Trust

Stephan M Röhrl, MD, PhD

Study Chair

Oslo University Hospital

About Helse Møre Og Romsdal Hf

Helse Møre og Romsdal HF is a prominent healthcare organization based in Norway, dedicated to providing high-quality medical services and advancing clinical research. As a regional health authority, it encompasses several hospitals and healthcare facilities, focusing on delivering comprehensive care while promoting innovation and evidence-based practices. The organization actively engages in clinical trials to enhance patient outcomes and contribute to the scientific community, fostering collaborations that aim to improve healthcare delivery and treatment options in various medical fields.

Locations

Kristiansund, Møre And Romsdal, Norway

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials